e-learning
resources
Vienna 2003
Saturday 27.09.2003
PG15 - Pleural diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How should we treat mesothelioma in 2003?
P. Astoul (Marseille, France)
Source:
Annual Congress 2003 - PG15 - Pleural diseases
Session:
PG15 - Pleural diseases
Session type:
Postgraduate Course
Number:
93
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Astoul (Marseille, France). How should we treat mesothelioma in 2003?. Annual Congress 2003 - PG15 - Pleural diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Diagnosis and staging of malignant pleural mesothelioma
Related content which might interest you:
Trends in mesothelioma diagnosis in Australia between 1993 and 2003
Source: Annual Congress 2005 - Old timers still around: fibres and inorganic dusts
Year: 2005
Malignant pleural mesothelioma: new treatments, new hopes?
Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017
Year: 2017
Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014
About 74 cases of pleural mesothelioma observed in the department between 2001 and 2011
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016
Malignant pleural mesothelioma: new treatment modalities
Source: Annual Congress 2005 - Clinical year in review
Year: 2005
Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Treating mesothelioma in 2021: what is the role of surgery and immunotherapy?
Source: Virtual Congress 2021 – Hot news from the pleura
Year: 2021
Mesothelioma: a hope in 2013?
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Source: Eur Respir Rev 2016; 25: 472-486
Year: 2016
Malignant mesothelioma (MM) in Metsovo, Greece from domestic use of tremolite asbestos; only one case since 2002
Source: Annual Congress 2010 - Mineral dusts and respiratory disease
Year: 2010
Late Breaking Abstract: Epidemiological tendencies in malignant mesotheliomas in Bulgaria during the 1990-2000 period
Source: Annual Congress 2010 - Indoor air and respiratory disease
Year: 2010
What is the best oncological management strategy for mesothelioma in 2018?
Source: International Congress 2018 – Malignant pleural effusions
Year: 2018
Surgery for mesothelioma: who are the long-term survivors?
Source: Breathe 2009; 6: 66
Year: 2009
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
Source: Eur Respir Rev 2015; 24: 115-131
Year: 2015
IPC-related pleural infection vs. colonisation - to treat or not to treat?
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept